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Background: Citrus intake has been suggested to increase the risk of skin cancer. Although 
this relation is highly plausible biologically, epidemiologic evidence is lacking. We aimed to 
examine the potential association between citrus intake and skin cancer risk. 
 
Methods: EPIC is an ongoing multi-center prospective cohort initiated in 1992 and involving 
~520,000 participants who have been followed-up in 23 centers from 10 European countries. 
Dietary data were collected at baseline using validated country-specific dietary 
questionnaires. We used Cox proportional hazards regression models to compute hazard ratios 
(HR) and 95% confidence intervals (CI). 
 
Results: During a mean follow-up of 13.7 years, 8,448 skin cancer cases were identified 
among 270,112 participants. We observed a positive linear dose-response relationship 
between total citrus intake and skin cancer risk (HR=1.10, 95%CI=1.03–1.18 in the highest 
vs. lowest quartile; Ptrend=0.001), particularly with basal cell carcinoma (BCC) (HR=1.11, 
95%CI=1.02–1.20, Ptrend=0.007) and squamous cell carcinoma (SCC) (HR=1.23, 95% 
CI=1.04–1.47, Ptrend=0.01). Citrus fruit intake was positively associated with skin cancer risk 
(HR=1.08, 95% CI=1.01–1.16, Ptrend=0.01), particularly with melanoma (HR=1.23, 95% 
CI=1.02–1.48; Ptrend=0.01), although with no heterogeneity across skin cancer types 
(Phomogeneity=0.21). Citrus juice was positively associated with skin cancer risk (Ptrend=0.004), 
particularly with BCC (Ptrend=0.008) and SCC (Ptrend=0.004), but not with melanoma 
(Phomogeneity=0.02). 
 
Conclusions: Our study suggests moderate positive linear dose-response relationships 
between citrus intake and skin cancer risk. Studies with available biomarker data and the 
ability to examine sun exposure behaviors are warranted to clarify these associations and 
examine the phototoxicity mechanisms of furocoumarin-rich foods. 
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Evidence suggests a potential association between citrus intake and skin cancer risk. Two 
large prospective cohort studies reported positive dose-response relationships between citrus 
consumption and the risks of cutaneous melanoma [1] and keratinocyte cancers (KC, 
including basal-cell (BCCs) and squamous-cell carcinomas (SCCs)) [2], in women from the 
Nurses’ Health Study (NHS) and men from the Health Professionals Follow-Up Study 
(HPFS), respectively. In addition, recently, a large prospective cohort study of 
postmenopausal women suggested a positive association between citrus juice intake and 
melanoma risk [3]. These associations are highly plausible biologically [4–6], since citrus 
products are rich in furocoumarins such as psolarens [7], which exhibit carcinogenic and 
phototoxic effects [8]. Higher intake of total furocoumarins has indeed been reported to be 
associated with an increased risk of skin cancer, particularly of KCs, in the NHS and HPFS 
cohorts [9]. Oral administration of psoralen (methoxsalen) and UVA radiation (PUVA) has 
been used for many years to treat psoriasis and other skin diseases [10], and both 
experimental and epidemiologic studies suggested that long-term PUVA therapy increases 
skin cancer risk [11–13]. It has also been shown that psoralens and furocoumarins can interact 
with UV light to stimulate the proliferation of melanoma cells [14]. However, epidemiologic 
data showing an association are lacking. 
 
Given the photosensitizing potential of furocoumarins and their known effects on skin, and 
given the intriguing associations described between citrus intake and skin cancer risk recently, 
a better understanding of the relationship between furocoumarin-rich foods and skin cancer 
risk is requested [4–6]. We sought to evaluate the associations between citrus consumption 
and skin cancer risk in the European Prospective Investigation into Cancer and Nutrition 




The EPIC cohort 
 
EPIC is a multi-center prospective cohort study initiated in 1992. The rationale, full methods, 
and study design have been described in detail elsewhere [16]. Briefly, 521,448 participants 
mostly aged 25–70 years were recruited in 23 centers from 10 European countries (France, 
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Italy, Spain, The Netherlands, United Kingdom, Greece, Germany, Sweden, Norway, and 
Denmark) between 1992 and 2000 [15,16]. All participants gave written informed consent, 
and approval for the study was obtained from local ethical committees in participating 




At baseline, dietary intakes over the 12 months before recruitment were assessed using 
validated country-specific dietary questionnaires designed to reflect local dietary patterns 
[17]. In the present study, the analyzed food groups were citrus fruits and citrus juices; these 
groups were analyzed overall, as no information on type of citrus fruit or juice was available 
in the cohort. Total intake of citrus was calculated as the sum of intakes of citrus fruits and 
juices, excluding centers in which no data were available on citrus juice intake (France, UK, 
and Norway). Detailed information on other lifestyle factors was collected using gender-
specific questionnaires common to all study centers [18]. 
 
Follow-up and identification of cancer cases 
 
Incident of cancer cases were identified through several methods, including record linkage 
with population-based cancer registries, health insurance records, pathology registries, and 
active follow-up of study subjects. Mortality data were obtained from cancer or mortality 
registries at the regional or national level. Skin cancer events were mostly ascertained through 
population-based cancer registries or pathology reports (96 % of cases; melanoma: 92 %; 
BCC: 96 %; SCC: 99 %), and a small proportion (4 %) was identified from hospital 
admission and discharge records or national/regional mortality registries. Registration of KC 
cases may be incomplete in some centers because these cancers are not systematically 
recorded in cancer registries. Follow-up began on the date of recruitment and ended on the 
date of skin cancer diagnosis, date of death, date of emigration/loss of follow-up, or date of 
completion of the last returned questionnaire, whichever came first. Cancer incidence data 
were coded according to the International Classification of Diseases for Oncology (ICD-O-3). 
Cancer cases were defined as subjects with a first primary incident skin cancer (including 
KCs; C44). Information on stage, site, morphology, and grade of melanoma was collected 





Study sample  
 
Of the 521,448 participants, we first excluded prevalent cancer cases (including KCs) or 
subjects with missing information on date of diagnosis and follow-up information (n=29,456), 
and those with missing information on lifestyle factors (n=6,259) or extreme energy intake 
values (<1st and >99th percentiles of the distribution) (n=9,573).  Because citrus consumption 
was our main exposure, and in order to conduct separate analyses for citrus fruit and juice and 
mutually adjust the models, we further excluded participants from the centers with no data on 
both citrus fruit and juice consumption (n=206,048 including participants from France 
(n=67,403), the UK (n=75,416), Norway (n=33,975), Naples (n=4,953), and Umea 




Statistical analyses were performed using the SAS package (version 9.4, SAS Institute). All 
significance tests were two-sided, p<0.05 being considered statistically significant. Hazard 
Ratios (HRs) and 95% confidence intervals (CIs) of the risks of overall skin cancer, 
melanoma, BCC, and SCC associated with citrus intake were estimated using Cox 
proportional hazards regression models with age as the time scale. We first evaluated 
associations between total citrus intake and skin cancer risk, and then assessed the association 
with citrus fruit and citrus juice intakes separately. Citrus intake was estimated in grams per 
day and divided into quartiles. Tests for linear trend were performed by modeling quartiles of 
intake as a continuous variable. Multivariable analyses were performed with adjustment for 
potential confounders such as lifestyle and dietary factors, which were selected based on 
previously published data [1,2,19]. Models were first adjusted for age and stratified by study 
center, sex, and age at recruitment (Model 1), then additionally adjusted for body mass index, 
smoking status, alcohol intake at baseline, physical activity level [18], and total energy intake 
(Model 2). A third model additionally included intakes of total vegetables, non-citrus fruits 
and juices, and coffee intake for total citrus (Model 3). This model then included different 
factors according to the type of citrus exposure: based on Model 2, analyses on citrus fruit 
were additionally adjusted for intakes of total vegetables, non-citrus fruits, citrus juice, and 
coffee. Again based on Model 2, analyses on citrus juice were additionally adjusted for 
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intakes of total vegetables, citrus fruit, non-citrus juice, and coffee. When data on categorical 
covariates were missing, a ‘missing’ category was introduced in the model. 
 
Since the consumption of citrus products differs across European countries, we conducted 
stratified analyses by country, using country-specific tertiles of intake. However, we checked 
that using tertiles of intake in the overall population for each exposure did not change our 
findings (data not shown). The analyses were also stratified according to sex. Using hours of 
recreational outdoor physical activity (combining physical exercise, walking, cycling, and 
gardening) in summer as a proxy for hours of recreational sun exposure, we evaluated 
potential effect modification by this factor using Wald tests. We further assessed the 
associations by tumor site and, for melanoma, histologic subtype, using competing-risk 
modeling, excluding cases with missing information on tumor characteristics for these 
analyses. Homogeneity tests were performed using Wald chi-square tests to compare 
estimates over tumor sites and types. Sensitivity analyses were carried out for the association 
between citrus fruit and skin cancer risk by including all study participants back in the 




During a mean follow-up of 13.7 years, 8,448 skin cancer cases (melanoma: n=1,371; BCC: 
n=5,604; SCC: n=1,165, unknown type: n=306) were identified among 270,112 participants. 
The mean intake of total citrus in the cohort was 90.9 g/day. Intakes varied across study 
locations, with the highest intakes observed in southern European countries (Spain, Italy, and 
Greece) and the lowest in Denmark (Table 1). Participants with high intakes of citrus were 
generally younger and more likely to be women, to have higher education and physical 
activity levels, and higher intakes of total energy, vegetables, non-citrus fruits, and non-citrus 
juices than those with low citrus intakes; however, they were less likely to be smokers and to 
consume alcohol and coffee (Table 2). 
 
Total citrus intake was positively associated with skin cancer risk (HR=1.10, 95%CI=1.03–
1.18 for the highest quartile vs. the lowest, Ptrend=0.001), particularly with BCC (HR=1.11, 
95%CI=1.02–1.20, Ptrend=0.007) and SCC (HR=1.23, 95%CI=1.04–1.47, Ptrend=0.01). We 
found no association with melanoma (HR=0.98, 95%CI=0.83–1.15, Ptrend=0.96), although 




When performing separate analyses for citrus fruit and juice, we found that citrus fruit intake 
was positively and linearly associated with skin cancer risk (HR=1.08, 95%CI=1.01–1.16 for 
the highest quartile vs. the lowest, Ptrend=0.01), particularly with melanoma (HR=1.23, 
95%CI=1.02–1.48, Ptrend=0.01) (Table 4). However, while we found positively linear 
associations with BCC and SCC in the age-adjusted model, associations were no longer 
statistically significant after adjustment, again with no heterogeneity across cancer types 
(Phomogeneity=0.21), although statistical significance remained in the fourth quartile of intake for 
SCC. Citrus juice intake was positively and linearly associated with skin cancer risk 
(HR=1.08, 95%CI=1.01–1.16 for the highest quartile vs. the lowest, Ptrend=0.004), particularly 
with BCC (HR=1.10, 95%CI=1.01–1.19, Ptrend=0.008) and SCC (HR=1.23, 95%CI=1.05–
1.44, Ptrend=0.004), but not with melanoma (HR=0.92, 95%CI=0.78–1.08, Ptrend=0.31) 
(Phomogeneity=0.02) (Table 5). These results were not substantially different after adjustment for 
hours of recreational sun exposure during outdoor physical activity in summer (data not 
shown). 
 
We found no evidence for effect modification by lifestyle factors on the associations between 
citrus intake and skin cancer risk (Supplementary Table S1), and no evidence for 
heterogeneity across countries (Supplementary Table S2) or sexes (Supplementary Table 
S3). In site-specific analyses, the positive associations between total citrus or citrus fruit 
intake and BCC risk were stronger for trunk tumors vs. those of the head, neck, and 
extremities (Phomogeneity=0.04 and 0.02, respectively) (Supplementary Table S4); however, we 
detected no heterogeneity across sites for melanoma and SCC, or in subtype-specific analyses 
(Supplementary Table S5).  
 
When participants from centers with no available data on citrus juice intake were included 
back in the analysis (total study sample: n=476,160), associations between citrus fruit intake 
and the risks of total skin cancer, BCC or SCC remained, although slightly reduced 
(Supplementary Table S6). However, a positive association with melanoma risk was no 






In this large European prospective study, we found a modest positive relationship between 
total citrus intake and skin cancer risk. Specifically, high intakes of citrus fruit were 
associated with higher melanoma risk, while citrus juice intake was positively and linearly 
associated with BCC and SCC risks. 
 
To date, only three US prospective cohort studies explored the associations between citrus 
intake and skin cancer risk [1–3]. In the NHS and HPFS cohorts, higher intakes of citrus were 
associated with higher skin cancer risk [1,2]; specifically, participants who consumed citrus 
over 1.6 times per day had 36%, 16%, and 21% higher risks of melanoma, BCC, and SCC, 
respectively, compared with those who consumed citrus less than twice per week. 
Consistently, our findings suggested that higher intakes of citrus (i.e. the fourth (mean=217.5 
g/day) vs. the first (mean=10.8 g/day) quartile of consumption) were associated with 11% and 
23% higher risks of BCC and SCC, respectively. However, we did not find an association 
with melanoma risk, although with no detected heterogeneity across cancer types, which is 
consistent with the results from the Women Health Initiative (WHI) that reported no 
association between total citrus intake and melanoma risk after adjustment for known skin 
cancer risk factors [3]. Nevertheless, we observed that participants in the highest quartile of 
citrus fruit intake (mean=147.5 g/day) had a 23% increased melanoma risk compared with 
those in the first (mean=4.4 g/day), with a positive linear trend. There was also a positive 
association between citrus fruit intake and SCC risk but not BCC risk. In contrast, while citrus 
juice intake was not associated with melanoma risk, we found positive and linear associations 
with BCC and SCC risks. Unfortunately, we were unable to examine associations by type of 
citrus fruit or juice, since this information was not available in the EPIC cohort. However, in 
the NHS and HPFS cohorts, associations were restricted to grapefruit for citrus fruit, and to 
orange juice for citrus juice [1,2]. In contrast with our findings, the WHI study reported non-
significant inverse association between citrus fruit intake and melanoma risk among 
postmenopausal women [3]. An Italian hospital-based case-control study also reported an 
inverse association between citrus fruit consumption and melanoma risk among 304 cases and 
305 controls [20]; however, diet was assessed retrospectively in that study and thus subject to 
recall bias.  
 
The  three previous prospective studies suggested a possible interaction by UV exposure on 
these associations [1,2]. Although we observed no interaction between citrus intake and hours 
of summer recreational outdoor physical activity (which we used as a proxy for recreational 
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sun exposure) in our analysis, the association appeared to be stronger for SCC among 
participants with higher levels of this variable. While this proxy incompletely reflects sun 
exposure, our findings lend support to those from the NHS and HPFS cohorts, which 
suggested that the positive associations between citrus intake and melanoma and SCC were 
stronger among participants with higher chronic sun exposure, those with a higher 
susceptibility to sunburn during childhood/adolescence, those with higher numbers of 
blistering sunburns, and those with higher annual residential UV flux. Also, our findings 
support those from the WHI study, in which an increased melanoma risk was observed in 
relation to citrus juice intake only among women who spent the most time outdoors in 
summer.   
 
Citrus products are widely consumed foods; the major citrus fruits consumed in Europe are 
oranges, followed by clementines/tangerines, grapefruit, and lemons [21]. A potential 
mechanism underlying the observed associations could be based on the presence in citrus of 
psoralens and furocoumarins, a well-known class of photosensitizers with potential 
photocarcinogenic properties [22,23]. Indeed, the NHS and HPFS cohorts have recently 
confirmed that participants with a high intake of total furocoumarins had higher risks of skin 
cancer, particularly of KCs [9]. Specifically, higher intakes of bergaptol, bergapten, 6’,7’-
dihydroxybergamottin, and bergamottin were also significantly associated with increased KC 
risk. Furocoumarins are found naturally in the fruit peel, roots, and leaves of citrus products. 
Average estimated intakes of furocoumarins in the US and Germany are of 1.3 and 0.6 mg per 
day, respectively, and grapefruit is estimated to contribute to around 73% of furocoumarin 
intake from foods in the Western diet [24,25]. Animal studies suggested that psoralen in the 
presence of UVA is mutagenic for the skin [26], and numerous observational studies have 
reported an increased risk of skin cancers in PUVA-treated psoriasis patients, including KCs 
and melanoma [11,27,28]. Clinical studies also indicate an increased risk of melanoma and 
KCs among patients treated with PUVA compared with the general population [11,29]. Orally-
ingested furocoumarins are well absorbed in the gastrointestinal tract and quickly transported 
in blood to numerous tissues including the skin [30,31], with a concentration peak in these 
tissues at 2-4 hours after consumption [32]. In the blood, furocoumarins can be distributed into 
multiple tissue types and allow DNA replication with damage, leading to carcinogenesis and 
the formation of skin tumors at high doses [33]. While DNA is the major target for psoralen 
action, leading to the stimulation of skin cell proliferation, psolarens may also bind to other 
specific and high-affinity sites in mammalian cells, which may modulate furocoumarin-
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induced phototoxicity [34]. Thus, a positive association between citrus intake and skin cancer 
risk that is heightened by UV exposure, as suggested by findings from the NHS, HPFS, WHI 
and this cohort, is highly plausible. Another hypothesis to explain the positive association 
between citrus fruit and melanoma risk is related to the potential contamination of citrus by 
pesticides. Previous research reported the presence of various pesticides in citrus fruits [35] 
and a positive association between several pesticides and melanoma risk [36]. 
 
Nevertheless, citrus products are also known to have antioxidant effects that could protect 
DNA against oxidative damage, regulate cell growth, and induce apoptosis [37]. They are also 
a significant source of vitamin C, and vitamin C-rich foods were suggested to protect against 
cancer risk [38]. Moreover, while citrus intake was positively associated with skin cancer risk 
in our study, citrus intakes were inversely associated with non-skin cancers (lung [39], gastric 
[29,30], prostate [40], and thyroid cancers [41]) in EPIC. However, citrus consumption was 
not associated with the risk of major non-skin cancers (breast, prostate, lung, and colorectal 
cancers) in the NHS/HPFS cohorts [1,2].  
 
In our study, when participants from centers with no available data on citrus juice intake were 
included back in the analysis, we no longer observed an association between citrus fruit and 
melanoma, although associations remained for other outcomes. Patterns of citrus fruit 
consumption differ across European countries, and it is possible that melanoma risk is more 
strongly associated with some types of citrus fruit, as suggested by the NHS/HPFS analyses in 
which associations were restricted to grapefruit [1,2]. It could be hypothesized that grapefruit 
consumption was less frequent in these centers. In addition, the processes undertaken by the 
agricultural and food industries, which may differ across European countries, may also 
influence furocoumarin contents in citrus [31,42,43]. However, since data on type of citrus 
fruit were not available, we were unable to clarify the origin of this divergent result. 
Additional research is requested in different countries with detailed data on type of citrus fruit 
and juice to increase our understanding of these associations. 
 
The main limitation of our study was the lack of information on recreational UV exposure; we 
cannot rule out residual confounding by this factor, since stratification by study center or 
adjustment for outdoor recreational physical activity may not have sufficiently attenuated this 
limitation. In addition, we lacked data on other skin cancer risk factors, such as pigmentary 
traits or family history of skin cancer. Moreover, combining data from different centers 
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increased statistical power, but also may have resulted in heterogeneity because of differences 
in study population characteristics. However, we found no evidence for heterogeneity across 
countries for these associations. Furthermore, information on type of citrus was not available 
in EPIC; therefore we were not able to examine associations by citrus type. However, 
exposure to furanocoumarins in a Western diet was reported to primarily come from 
grapefruit juice [44], and grapefruit and orange juice intakes showed the strongest associations 
with melanoma, BCC, and SCC risks in the NHS and HPFS. In addition, dietary intakes and 
confounding factors were self-reported and some degree of misclassification cannot be 
excluded. However, such misclassification is likely to be non-differential, which would most 
likely result in an underestimation of the associations. In EPIC, diet was evaluated through a 
single dietary assessment at recruitment, which did not allow to take into account potential 
dietary changes during follow-up. Also, while skin cancer cases were ascertained with high 
confirmation rates, KCs are often not systematically recorded in cancer registries; thus, 
underestimation of the incidence of these cancers in some centers is likely. Despite these 
limitations, our study has several strengths, including its prospective design, particularly large 
study population and long duration of follow-up, and the fact that it spans a large number of 
European countries with a high variety of dietary profiles. In addition, dietary intake was 
assessed using validated dietary questionnaires in all centers. 
 
In conclusion, our findings suggest modest positive linear relationships between citrus intake 
and skin cancer risk, which were mostly driven by associations with BCC and SCC. While 
high citrus fruit intakes were associated with melanoma risk, citrus juice intake was positively 
and linearly associated with BCC and SCC risks. Although additional studies are needed 
because of limited data on UV exposure and type of citrus fruit and juice in this analysis, the 
current findings lend support to previous research. Further studies with biomarker data, 
availability of detailed data on type of citrus, and the ability to examine UV exposure 
behaviors are warranted to clarify these associations and to examine the phototoxicity 
mechanisms of furocoumarin-rich foods. 
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1 Mean (SD)
Table 1: Cohort characteristics by country, European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study (n=476,160) 
Cohort size 








Total citrus intake 
(g/day) 1 
Citrus fruit intake 
(g/day)1 
Citrus juice intake 
(g/day)1 
Cohorts with available 
data on citrus juice and 
fruit intakes 270,112 52.3 (9.3) 1991-1999 13.7 (4.3) 60.3 90.9 (97.2) 56.3 (71.8) 34.6 (69.2) 
Italy 39,592 50.5 (7.9) 1992-1998 13.9 (3.3) 64.5 110.9 (102.9) 84.7 (83.0) 26.1 (52.4) 
Spain 39,989 49.2 (8.0) 1992-1996 15.8 (3.2) 62.2 115.8 (113.3) 99.0 (104.4) 16.3 (47.4) 
The Netherlands 36,539 48.9 (11.9) 1994-1996 14.3 (3.3) 73.7 92.0 (76.5) 46.4 (40.4) 45.6 (59.4) 
Germany 48,557 50.5 (8.5) 1994-1998 10.4 (3.2) 56.4 82.4 (106.5) 19.8 (19.3) 62.6 (102.6) 
Denmark 55,014 56.6 (4.3) 1993-1997 14.4 (4.3) 52.2 64.5 (75.7) 35.0 (47.3) 29.6 (53.1) 
Greece 26,048 53.1 (12.6) 1993-1999 10.8 (3.6) 58.5 99.7 (88.6) 95.6 (88.3) 4.1 (1.8) 
Sweden 24,373 57.9 (7.5) 1991-1996 16.4 (5.6) 57.9 83.6 (100.9) 33.2 (35.3) 50.5 (92.4) 
France 67,403 52.7 (6.6) 1993-1997 12.8 (3.5) 100 - 37.8 (40.5) - 
United Kingdom 75,416 51.6 (11.1) 1993-2001 14.7 (4.00) 69.7 - 43.2 (54.9) - 
Norway 33,975 48.3 (4.3) 1998 13.3 (2.5) 100 - 26.1 (37.0) - 
Naples 4,953 50.5 (7.3) 1993-1997 15.0 (2.6) 100 - 87.8 (62.2) - 
Umea 24,301 47.7 (8.1) 1992-1996 16.5 (4.3) 50.5 - 51.3 (58.2) - 




Table 2: Baseline characteristics of study participants according to quartile of total citrus intake, EPIC cohort 
(n=270,112) 
 
  Quartile 1 Quartile 2 Quartile 3 Quartile 4 
Participants (n)   67,527 67,603 67,454 67,528 
Mean (SD) of total citrus intake 
(g/day)   10.83 (7.72) 44.20 (11.0) 90.90 (15.9) 217.5 (112.7) 
Women (%)   50.3 59.9 65.0 65.9 
Age at recruitment (years)    53.5 (8.8) 52.1 (9.4) 52.0 (9.6) 51.7 (9.3) 
Body mass index, kg/m2 (%)           
<18.5   1.0 0.8 0.6 0.6 
18.5-24.9   39.8 41.6 40.0 38.8 
25-29.9   41.8 40.7 40.8 41.8 
≥30   17.4 16.9 18.6 18.8 
Education (%)           
None/primary   43.0 37.2 41.6 41.7 
Technical/secondary school   38.8 40.8 38.3 37.2 
University degree   17.9 21.8 19.8 20.8 
Unknown   0.3 0.2 0.3 0.3 
Smoking (%)           
Never smoker   35.8 43.6 47.9 48.8 
Former smoker   28.8 28.7 26.8 26.4 
Current smoker   35.0 27.0 24.4 24.0 
Unknown   0.4 0.6 0.9 0.8 
Alcohol intake, g/day (%)           
Non-consumer   13.0 12.4 14.8 17.6 
>0-2.09   14.2 16.3 18.1 17.8 
2.10-7.14   16.5 18.5 18.6 18.6 
7.15-17.30   22.4 23.6 22.5 21.4 
>17.31   33.9 29.2 25.9 24.6 
Physical activity (%)           
Inactive    20.8 19.4 16.6 16.2 
Moderately inactive   30.6 27.4 25.4 25.4 
Moderately active   38.2 41.0 45.0 45.9 
Active   8.87 10.0 11.0 10.9 
Missing   1.57 2.3 2.0 1.6 
Total energy intake (kcal/day) 1   2085.4 (632.2) 2097.71 (619.9) 2142.46 (623.3) 2259.5 (659.2) 
Coffee (g/day) 1   535.25 (475.6) 428.30 (402.8) 358.47 (370.3) 320.0 (342.0) 
Vegetable (g/day) 1   159.24 (115.9) 181.14 (128.5) 215.99 (151.5) 225.5 (166.5) 
Citrus juice (g/day) 1   3.12 (4.4) 13.10 (15.0) 28.27 (32.9) 93.9 (113.1) 
Citrus fruit (g/day) 1   7.71 (6.6) 31.10 (16.4) 62.62 (33.0) 123.6 (108.0) 
Non-citrus fruit (g/day) 1  113.42 (113.6) 153.50 (105.7) 201.02 (120.2) 248.3 (172.4) 
Non-citrus juice (g/day) 1  18.71 (74.1) 28.99 (75.9) 32.17 (75.2) 45.6 (108.3) 
      
Abbreviations: EPIC, European Prospective Investigation into Cancer and Nutrition; SD, standard deviation 




Table 3: Hazard ratios (HRs) and 95% confidence intervals (CIs) for intake of total citrus and risk of skin cancer, EPIC 
cohort (n=270,112) 
  Total citrus intake   
  Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-trend 
N 67,527 67,603 67,454 67,528   
Mean (g/day) 10.8 44.2 90.9 217.5   
Skin cancer           
No cases 2,586 2,119 1,955 1,788   
Age-adjusted HR (95% CI) 1 (ref) 1.11 (1.05-1.18) 1.17 (1.10-1.25) 1.17 (1.10-1.24) <.0001  
Multivariable-adjusted HR1 (95% CI) 1 (ref) 1.08 (1.02-1.15) 1.13 (1.06-1.20) 1.12 (1.05-1.19) 0.0001 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 1.07 (1.01-1.13) 1.11 (1.04-1.19) 1.10 (1.03-1.18) 0.001 
Melanoma           
No cases 395 340 323 313   
Age-adjusted HR (95% CI) 1 (ref) 1.01 (0.87-1.17) 1.09 (0.94-1.27) 1.04 (0.89-1.21) 0.44 
Multivariable-adjusted HR1 (95% CI) 1 (ref) 0.98 (0.85-1.14) 1.05 (0.90-1.23) 1.00 (0.85-1.17) 0.78 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 0.97 (0.83-1.13) 1.03 (0.88-1.21) 0.98 (0.83-1.15) 0.96 
BCC           
No cases 1,797 1,416 1,290 1,101   
Age-adjusted HR (95% CI) 1 (ref) 1.12 (1.05-1.21) 1.17 (1.09-1.26) 1.17 (1.08-1.27) <.0001  
Multivariable-adjusted HR1 (95% CI) 1 (ref) 1.09 (1.01-1.17) 1.12 (1.05-1.21) 1.12 (1.03-1.21) 0.001 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 1.08 (1.00-1.16) 1.11 (1.03-1.20) 1.11 (1.02-1.20) 0.007 
SCC           
No cases 312 282 262 309   
Age-adjusted HR (95% CI) 1 (ref) 1.14 (0.97-1.34) 1.21 (1.02-1.44) 1.28 (1.09-1.51) 0.002 
Multivariable-adjusted HR1 (95% CI) 1 (ref) 1.12 (0.95-1.32) 1.18 (1.00-1.41) 1.25 (1.06-1.48) 0.007 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 1.11 (0.94-1.31) 1.17 (0.98-1.39) 1.23 (1.04-1.47) 0.01 
 
Abbreviations: BCC, basal-cell carcinoma; CI, confidence intervals; EPIC, European Prospective Investigation 
into Cancer and Nutrition; HR, hazard ratio; SCC, squamous-cell carcinoma 
 Age-adjusted: adjusted for age and stratified by study center, sex, and age at recruitment  
1 Stratified by study center, sex, age at recruitment, and adjusted for education (none, primary school, 
technical/professional school, secondary school, university or higher degree), body mass index (BMI; <25, 25–
29, or ≥30 kg/m2), smoking (never, former, and current), alcohol intake (non-consumer, then categorized in 
quartiles, g per day), physical activity (metabolic equivalent of task [MET] hour/week), and energy intake 
(continuous) 
2 Additionally adjusted for total vegetable intake (tertiles), coffee intake (tertiles), non-citrus fruit intake 




Table 4: Hazard ratios (HRs) and 95% confidence intervals (CIs) for intake of citrus fruit and risk of skin cancer, EPIC 
cohort (n=270,112) 
  Citrus fruit intake   
  Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-trend 
N 67,297 67,756 67,531 67,528   
Mean (g/day) 4.4 20.2 52.8 147.5   
Skin cancer           
No cases 2,540 1,968 2,126 1,814   
Age-adjusted HR (95% CI) 1 (ref) 1.08 (1.02-1.15) 1.14 (1.07-1.21) 1.15 (1.08-1.23) <.0001 
Multivariable-adjusted HR1 (95% CI) 1 (ref) 1.04 (0.98-1.11) 1.10 (1.04-1.17) 1.12 (1.04-1.19) 0.0003 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 1.03 (0.97-1.09) 1.07 (1.01-1.15) 1.08 (1.01-1.16) 0.01 
Melanoma           
No cases 360 359 364 288   
Age-adjusted HR (95% CI) 1 (ref) 1.07 (0.92-1.24) 1.20 (1.03-1.39) 1.27 (1.07-1.51) 0.002 
Multivariable-adjusted HR1 (95% CI) 1 (ref) 1.04 (0.90-1.21) 1.16 (1.00-1.36) 1.24 (1.04-1.47) 0.007 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 1.05 (0.90-1.22) 1.17 (0.99-1.37) 1.23 (1.02-1.48) 0.01 
BCC           
No cases 1,817 1,213 1,372 1,202   
Age-adjusted HR (95% CI) 1 (ref) 1.06 (0.98-1.14) 1.13 (1.05-1.21) 1.10 (1.01-1.19) 0.003 
Multivariable-adjusted HR1 (95% CI) 1 (ref) 1.01 (0.94-1.09) 1.09 (1.01-1.17) 1.06 (0.97-1.15) 0.06 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 0.99 (0.92-1.07) 1.05 (0.98-1.14) 1.02 (0.94-1.11) 0.37 
SCC           
No cases 282 332 297 254   
Age-adjusted HR (95% CI) 1 (ref) 1.24 (1.05-1.46) 1.11 (0.93-1.31) 1.33 (1.10-1.60) 0.01 
Multivariable-adjusted HR1 (95% CI) 1 (ref) 1.22 (1.03-1.43) 1.08 (0.91-1.29) 1.30 (1.08-1.57) 0.03 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 1.18 (1.00-1.40) 1.05 (0.88-1.25) 1.26 (1.03-1.54) 0.10 
      
 
Abbreviations: BCC, basal-cell carcinoma; CI, confidence intervals; EPIC, European Prospective Investigation 
into Cancer and Nutrition; HR, hazard ratio; SCC, squamous-cell carcinoma 
 Age-adjusted: adjusted for age and stratified by study center, sex, and age at recruitment  
1 Stratified by study center, sex, age at recruitment, and adjusted for education (none, primary school, 
technical/professional school, secondary school, university or higher degree), body mass index (BMI; <25, 25–
29, or ≥30 kg/m2), smoking (never, former, and current), alcohol intake (non-consumer, then categorized in 
quartiles, g per day), physical activity (metabolic equivalent of task [MET] hour/week), and energy intake 
(continuous) 
2 Additionally adjusted for total vegetable intake (tertiles), non-citrus fruits (tertiles), citrus juice (tertiles) and 







Table 5: Hazard ratios (HRs) and 95% confidence intervals (CIs) for intake of citrus juice and risk of skin cancer, EPIC 
cohort (n=270,112) 
 Citrus juice intake  
  Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-trend 
N 67,364 67,692 67,268 67,788   
Mean (g/day) 0.01 2.8 17.6 117.7   
Skin cancer           
No cases 2,089 1,725 2,154 2,480   
Age-adjusted HR (95% CI) 1 (ref) 1.03 (0.96-1.10) 1.10 (1.03-1.17) 1.16 (1.09-1.23) <.0001  
Multivariable-adjusted HR1 (95% CI) 1 (ref) 0.99 (0.93-1.06) 1.04 (0.98-1.12) 1.09 (1.02-1.16) 0.002 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 0.99 (0.92-1.06) 1.04 (0.97-1.11) 1.08 (1.02-1.16) 0.004 
Melanoma           
No cases 395 255 349 372   
Age-adjusted HR (95% CI) 1 (ref) 1.04 (0.87-1.23) 1.07 (0.92-1.26) 0.96 (0.83-1.12) 0.64 
Multivariable-adjusted HR1 (95% CI) 1 (ref) 1.01 (0.85-1.20) 1.03 (0.88-1.21) 0.92 (0.79-1.07) 0.30 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 1.01 (0.84-1.21) 1.03 (0.87-1.22) 0.92 (0.78-1.08) 0.31 
BCC           
No cases 1,244 1,225 1,501 1,634   
Age-adjusted HR (95% CI) 1 (ref) 1.03 (0.95-1.12) 1.10 (1.02-1.20) 1.19 (1.10-1.29) <.0001  
Multivariable-adjusted HR1 (95% CI) 1 (ref) 0.99 (0.91-1.07) 1.04 (0.96-1.13) 1.11 (1.02-1.20) 0.004 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 0.99 (0.91-1.07) 1.04 (0.95-1.13) 1.10 (1.01-1.19) 0.008 
SCC           
No cases 362 179 237 387   
Age-adjusted HR (95% CI) 1 (ref) 1.01 (0.84-1.22) 1.20 (1.00-1.43) 1.29 (1.11-1.50) 0.0004 
Multivariable-adjusted HR1 (95% CI) 1 (ref) 0.98 (0.81-1.19) 1.16 (0.97-1.39) 1.25 (1.07-1.46) 0.001 
Multivariable-adjusted HR2 (95% CI) 1 (ref) 0.95 (0.78-1.16) 1.11 (0.92-1.35) 1.23 (1.05-1.44) 0.004 
      
 
Abbreviations: BCC, basal-cell carcinoma; CI, confidence intervals; EPIC, European Prospective Investigation 
into Cancer and Nutrition; HR, hazard ratio; SCC, squamous-cell carcinoma 
 Age-adjusted: adjusted for age and stratified by study center, sex, and age at recruitment  
1 Stratified by study center, sex, age at recruitment, and adjusted for education (none, primary school, 
technical/professional school, secondary school, university or higher degree), body mass index (BMI; <25, 25–
29, or ≥30 kg/m2), smoking (never, former, and current), alcohol intake (non-consumer, then categorized in 
quartiles, g per day), physical activity (metabolic equivalent of task [MET] hour/week), and energy intake 
(continuous). 
2 Additionally adjusted for total vegetable intake (tertiles), citrus fruit (tertiles), non-citrus juice (tertiles) and 
coffee intake (tertiles). Phomogeneity for citrus juice and skin cancer type was 0.02 
